Qiagen N.V. (QGEN) has a market capitalization of $8.61B and trades at $41.76. The 52-week range is 38.58-57.82.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 20.5, Earnings Per Share (EPS) of $2.04, annual revenue of $2.09B.
The stock has a beta of 0.79, a last dividend of $0.2600, operates in the Healthcare sector.
